Unknown intervention -> Unknown outcome
New study added to the Dediabetes evidence system.
Weekly evidence changelog
A weekly summary of studies, interventions, outcomes, and evidence relationships added to Dediabetes.
Changes reflect content added to Dediabetes during this week and may include studies published earlier.
Featured
The most notable evidence graph changes detected in this weekly snapshot.
New study added to the Dediabetes evidence system.
Diet and Nutrition · Metabolic Health
New evidence relationship detected from studies added this week.
Diet and Nutrition · Metabolic Health
New evidence relationship detected from studies added this week.
Diet and Nutrition · Metabolic Health
New evidence relationship detected from studies added this week.
New relationships
Showing the top 10 relationships first from content added to Dediabetes during this week.
Diet and Nutrition · Metabolic Health
New evidence relationship detected from studies added this week.
Diet and Nutrition · Metabolic Health
New evidence relationship detected from studies added this week.
Diet and Nutrition · Metabolic Health
New evidence relationship detected from studies added this week.
Medications · Safety
New evidence relationship detected from studies added this week.
Medications · Clinical Outcomes
New evidence relationship detected from studies added this week.
Medications · Clinical Outcomes
New evidence relationship detected from studies added this week.
Medications · Safety
New evidence relationship detected from studies added this week.
Medications · Clinical Outcomes
New evidence relationship detected from studies added this week.
Medications · Safety
New evidence relationship detected from studies added this week.
Medications · Clinical Outcomes
New evidence relationship detected from studies added this week.
Studies
Studies added to the Dediabetes evidence system during this weekly snapshot.
This study tested the SGLT2 inhibitor empagliflozin in 79 people with type 2 diabetes and early kidney disease over 24 weeks. While empagliflozin showed early improvements in albumin excretion at 4 and 12 weeks, the difference was not significant by 24 weeks. However, it did reduce certain hypoxia-related proteins in the blood that may contribute to kidney damage.
This trial tested a carob-based liquid concentrate in people with confirmed prediabetes. After 90 days, the supplement group had better HbA1c, glucose responses, and insulin-related markers than the placebo group, with no adverse effects reported.
This study tested a community lifestyle programme for adults with prediabetes in Malaysia. After 12 months, people in the programme had lower blood sugar, better cholesterol, smaller waists, and improved quality of life compared to those receiving usual care. The programme was delivered through existing community volunteers.
This study looked at whether attending more sessions of a diabetes prevention programme helped lower type 2 diabetes risk. People who went to all sessions had an 88% lower risk of developing diabetes compared to those receiving standard care. However, fewer than 1 in 3 people attended all sessions.
This study combined data from three European trials of lifestyle programmes for people with prediabetes. The lifestyle programme cut diabetes risk by 57% overall, and those who lost 5% or more of their body weight in the first year had a 65% lower risk. Keeping the weight off for longer led to even greater protection.
This study followed adults at high risk of type 2 diabetes after a primary-care lifestyle programme in Poland. Among the 105 people with complete 3-year follow-up, many lost weight during the intervention and a smaller subgroup kept that weight off afterward. Because there was no concurrent control group in this analysis, the findings should be interpreted cautiously.
This study tested a lifestyle programme for new mothers who had gestational diabetes, to help prevent later type 2 diabetes. Women in the programme maintained their weight while those receiving usual care gained weight over 12 months. However, most women did not fully participate in the programme, and there were no clear improvements in waist size or blood sugar.
This study tested whether prediabetes type affects how well resistance training improves blood sugar handling. 159 older adults with prediabetes did supervised strength training twice weekly for 12 weeks. 2-hour glucose tolerance improved in those with impaired glucose tolerance, but not in those with isolated impaired fasting glucose.
This study tested monthly physiotherapist-led exercise guidance supported by wearable device feedback in people with type 2 diabetes, including diabetic kidney disease. Over six months, the intervention group walked farther and had lower HbA1c than the standard care group, while kidney filtration did not clearly change.
This randomized trial tested an early Mediterranean diet intervention during pregnancy. Women assigned to extra virgin olive oil and pistachios had fewer gestational diabetes diagnoses and better several maternal and neonatal outcomes than women given standard low-fat diet advice.
This 12-week trial tested oxygen-enriched ELO water as an add-on therapy in adults with type 2 diabetes. HbA1c fell modestly in the ELO group, especially by week 6 compared with placebo, but fasting glucose and body weight did not clearly improve.
This cluster-randomized trial tested a community-based peer-support lifestyle program in 1,007 high-risk Indian adults. The program improved diet, reduced alcohol use, and enhanced physical functioning, but the 14.9% vs 17.1% reduction in diabetes incidence was not statistically significant.
This trial tested whether adults with prediabetes could start and maintain resistance training. After a supervised 3-month training phase, about one-third of participants were no longer prediabetic, and this was mostly maintained through 15 months. Extra social-cognitive support did not outperform lower-contact standard care.
This small trial analysis tested daily tadalafil in people with type 2 diabetes. Tadalafil lowered some blood biomarkers related to amyloid metabolism and astroglial activation, but it did not change several other brain-related biomarkers.
This study evaluated the effects of a multi-species synbiotic preparation on metabolic profiles in elderly patients with type 2 diabetes and high cardiovascular risk, finding significant reductions in weight, cholesterol, and glucose levels.
This study investigated the effects of dapagliflozin on the renin-angiotensin-aldosterone system in patients with type 2 diabetes, finding significant changes in several metabolic parameters.
The Daqing Diabetes Prevention Study II investigated the effectiveness of different lifestyle interventions on diabetes risk among adults in China. Results regarding the effectiveness of these interventions remain unclear.
This study evaluated the cost-effectiveness of various glucose-lowering agents in type 2 diabetes patients, finding significant reductions in HbA1c levels.
This study analyzed the long-term cost-effectiveness of IDegLira for treating type 2 diabetes in China, showing significant improvements in glycemic control and health outcomes.
This study evaluated the effectiveness of insulin glargine-lixisenatide fixed-ratio combination (iGlarLixi) in individuals with type 2 diabetes. It found significant improvements in body weight, BMI, and insulin dosage compared to multiple daily injections (MDI).
This study investigated the effects of interval walking on postprandial glycemic control in individuals with type 2 diabetes, finding significant improvements with one of the walking interventions.
This study evaluated the effects of a one-year lifestyle intervention on type 2 diabetes patients who achieved remission, finding significant improvements in various metabolic parameters.
This study will investigate a lifestyle intervention aimed at preventing type 2 diabetes in Asian women with a history of gestational diabetes.
This study explored a machine learning framework for predicting postprandial glycemic events in individuals with Type 1 Diabetes, demonstrating reductions in both hypoglycemia and hyperglycemia incidences.
This study evaluated the postprandial effects of three diets in patients with type 2 diabetes, finding significant differences in insulin and glucose responses.
This study investigated the potential of natural product-based treatments for type 2 diabetes and cardiovascular disease, finding significant reductions in various health markers.
This study investigated the impact of peripheral electrical stimulation on glucose control in type 2 diabetes patients, showing significant improvements in nocturnal glucose control.
This study investigated the acute effects of raw cinnamon on post-meal glucose spikes in type 2 diabetes patients, finding that cinnamon in water reduced glucose spikes while capsules did not.
This study evaluated the impact of tighter glycaemic control in women with gestational diabetes. It found a reduction in serious health outcomes for infants but an increase in serious maternal health outcomes.
This study evaluated the effects of a combined arm rotation and walking exercise regimen on glycemic control in type 2 diabetes, finding significant reductions in postprandial blood glucose and HbA1c levels.
This study evaluated the efficacy and safety of Bifidobacterium longum subsp. longum BL21 as an adjunctive therapy to metformin in patients with type 2 diabetes, finding a significant reduction in HbA1c levels.
This study examined the impact of continuous glucose monitoring on glycemic control in diabetes patients, finding significant reductions in HbA1c and fasting plasma glucose levels.
The study evaluated the effects of a curcumin-piperine combination on mental health and physical factors in diabetic retinopathy patients, showing significant improvements in various outcomes.
This study evaluated the combination therapy of Dapagliflozin and Linagliptin in managing Type 2 Diabetes and hypertension, showing significant improvements in various health metrics.
This study evaluated a digital-driven physician-pharmacist collaborative model for managing Type 2 diabetes in underresourced settings, finding significant improvements in several health outcomes.
The study evaluated the effects of a diabetes-specific nutritional formula (DSNF-Pro) on postprandial glycemic control in prediabetic participants, finding significant reductions in glucose and c-peptide levels compared to a standard formula.
EWP supplementation improved nutritional status and reduced oxidative stress in diabetic hemodialysis patients.
This study investigated the effects of high-dose Vitamin D3 supplementation on insulin resistance and glycaemic control in adult males with type 2 diabetes. It found no significant differences in key metabolic outcomes between the intervention and placebo groups.
Switching from premixed insulin to the insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) improved glycemic control in participants with type 2 diabetes.
This study evaluated the effects of six-month magnesium citrate supplementation on calciprotein crystallization and arterial stiffness in older individuals with type 2 diabetes and peripheral MAC, finding no significant reductions.
This study evaluated the effects of mulberry twig alkaloids combined with continuous subcutaneous insulin infusion on glycemic variability in type 2 diabetes patients, finding significant improvements in several glycemic metrics.
This study compared the effectiveness of nutritional therapy and alpha-glucosidase inhibitors in managing type 2 diabetes, finding significant reductions in glucose levels with both interventions.
This study investigated whether multi-strain probiotic supplementation enhances the metabolic effects of metformin in women with elevated HOMA-IR, finding no significant improvements.
This study evaluated the effects of semaglutide combined with insulin therapy on glycemic control and renal function in elderly patients with type 2 diabetes, finding significant improvements in several metabolic parameters.
This study investigated the impact of 24-week Taichi training on pulmonary diffusion capacity and glycemic control in patients with Type 2 Diabetes Mellitus, finding significant improvements in several health markers.
This study examined the effects of vitamin D supplementation on oxidative stress, inflammation, and pregnancy outcomes in women with gestational diabetes mellitus, finding significant changes in several biomarkers.
This study investigated the effects of aerobic exercise and saffron supplementation on insulin resistance and inflammation in obese women with type 2 diabetes, finding significant improvements in several health markers.
This study investigated the effects of carnosine supplementation on depressive symptoms in individuals with prediabetes and well-controlled type 2 diabetes, finding a significant reduction in depressive symptoms.
This study evaluated the safety and efficacy of Centella asiatica as a dietary supplement for glycemic control in individuals with type 2 diabetes, finding a significant reduction in HbA1c levels.
This study evaluated the effectiveness of encapsulated cinnamon in reducing body measurements in individuals with Type 2 diabetes, but results were inconclusive.
This study evaluated the effects of combined antioxidant and prebiotic supplementation on type 2 diabetes outcomes, finding significant improvements in fasting plasma glucose and glycated hemoglobin.
Curcumin supplementation was studied for its effects on inflammatory and glycemic profiles in adults with type 2 diabetes, showing significant improvements in several key metrics.
This study investigated the effects of dietary supplements on the risk of developing diabetes in individuals with prediabetes, finding that certain interventions reduced progression to overt diabetes.
This randomized controlled trial investigated the effects of the dietary supplement EDC-HHA01 on metabolic health, finding significant reductions in HbA1c and insulin levels compared to placebo.
This study investigated the effects of Luseogliflozin combined with leucine-enriched amino acid supplementation and exercise in older adults with type 2 diabetes. It found a decrease in HbA1c and body weight over 52 weeks.
This study investigated the effects of magnesium and potassium supplementation on cholesterol levels and quality of life in patients with type 2 diabetes mellitus, finding significant improvements in both areas.
This study investigated the effects of magnesium oxide supplementation on glycemic control in older adults with pre-diabetes and hypomagnesemia, finding a significant reduction in fasting plasma glucose.
This study evaluated the effects of a multi-strain probiotic formula on inflammation, metabolism, and gut microbiota in patients with Type 2 Diabetes Mellitus, finding significant reductions in several inflammatory markers and metabolic indicators.
This study investigated the effects of Limosilactobacillus reuteri supplementation on the subgingival microbiome in diabetic patients, finding no significant alterations.
This study investigated the impact of Vitamin D supplementation on the Ankle-Brachial Index (ABI) in patients with Type 2 Diabetes, finding significant improvements in several metabolic markers.
This study investigated the effects of Vitamin D3 supplementation on oxidative stress markers and NLRP3 gene expression in patients with Type 2 Diabetes, finding significant increases in vitamin D3 levels and reductions in NLRP3 expression.
Astaxanthin supplementation significantly reduced inflammation-related microRNAs and improved metabolic markers in type 2 diabetes patients.
This study investigated the effects of cholecalciferol on depression in patients with type 2 diabetes, finding significant improvements in depression scores compared to placebo.
L-Citrulline supplementation added to standard treatment in adults with type 2 diabetes.
Citrus bioflavonoid-based nutraceutical added to metformin in prediabetic individuals.
This study investigated the effects of coriander seed supplementation on glycemic indices and lipid profiles in patients with type 2 diabetes, finding significant reductions in several health markers.
The study evaluated the impact of a diabetes-specific protein supplement (DSPS) as a partial breakfast replacement on glycemic control in adults with type 2 diabetes, finding significant reductions in postprandial glucose levels.
This study examined the effects of fish oil-derived omega-3 fatty acids on gut microbiota and serum lipid metabolites in individuals with Type 2 Diabetes Mellitus (T2DM). The fish oil group showed significant improvements in various metabolic markers compared to the corn oil control group.
This case report examined the effects of high-dose vitamin D therapy on partial clinical remission in a participant with Type 1 Diabetes.
This study investigated the effects of inulin-type fructans on serum levels of calcium, magnesium, and vitamin D in individuals with type 2 diabetes, finding no significant improvements.
Magnesium supplementation compared with placebo in adults with type 2 diabetes.
This study investigated the effect of myrtle syrup on proteinuria in patients with type 2 diabetes, finding a significant decrease in urine protein levels compared to placebo.
BL21 probiotic added to metformin in adults with type 2 diabetes.
This study investigated the effects of multispecies probiotic supplementation on glycemic control in individuals with type 2 diabetes over 24 weeks, finding significant reductions in HbA1c and increases in HDL-c.
This study investigated the effects of resistance training combined with protein or carbohydrate supplementation on muscle strength and insulin resistance in older adults with type 2 diabetes. The protein group showed significant improvement in insulin resistance.
Moderate and vigorous exercise program with or without vitamin D supplementation in adults with type 2 diabetes.
This study investigated the effects of vitamin D supplementation on glycemic control in newly diagnosed type 2 diabetes patients. No significant differences were found between the vitamin D group and the standard anti-diabetic drugs group.
This study investigated the impact of whole-grain intake on vitamin D levels in pre-diabetic individuals, finding improvements with both 50g and 100g daily interventions.
The ASCEND study investigated cardiovascular events in diabetic participants through a randomized controlled trial involving aspirin and omega-3 fatty acid supplementation.
This study evaluated the effects of Dulaglutide on weight loss in a morbidly obese patient with type 2 diabetes, resulting in significant weight reduction and improved glycemic control.
This study evaluated the efficacy and safety of generic semaglutide compared to innovator semaglutide in Indian adults with type 2 diabetes inadequately controlled on metformin, finding non-inferior results.
This study evaluated the addition of glargine, glimepiride, liraglutide, or sitagliptin to metformin in type 2 diabetes. It found varying rates of hypoglycemia among the different treatments.
This study evaluated the effects of higher doses of semaglutide on glucose levels in type 2 diabetes patients, finding modest additional benefits at higher doses.
This study evaluated the efficacy and safety of HRS-7535 in adults with type 2 diabetes inadequately controlled with metformin, showing significant reductions in HbA1c and fasting plasma glucose levels.
The study evaluated the effects of Mazdutide on an adolescent with obesity-related type 2 diabetes, showing significant improvements in metabolic parameters.
This study examined the effects of Metformin and Liraglutide on the gut microbiome in youth with type 2 diabetes, revealing significant changes in microbial abundance and metabolic markers.
This Phase 3 trial evaluated a novel semaglutide injection in Indian adults with Type 2 diabetes, showing significant reductions in HbA1c and body weight.
This study evaluated the effectiveness of pharmacotherapy for achieving diabetes remission. It found that both intervention and control groups had patients in remission, with notable weight loss in the intervention group.
This study evaluated the effects of sitagliptin on carotid intima-media thickness in type 2 diabetes patients. It found no significant change in IMT but a notable reduction in HbA1c levels.
The study analyzed the efficacy of tirzepatide in patients with type 2 diabetes, showing significant reductions in HbA1c, body weight, and fasting serum glucose.
This study analyzed the sustainability of glycemic control and weight loss with tirzepatide in type 2 diabetes patients, showing significant maintenance of HbA1c and weight loss.
The study investigated the effects of tirzepatide on HbA1c levels, highlighting the role of weight loss in these reductions.
This study evaluated the efficacy and durability of initial combination therapies for Type 2 Diabetes, finding that initial triple therapy showed lower liver fat content compared to sequential therapy.
This study investigated the effects of vitamin D supplementation on type 2 diabetes risk in older adults, finding no significant reduction in diabetes events.
This study investigated the neuroprotective effects of dapagliflozin and liraglutide in patients with type 2 diabetes, highlighting distinct outcomes on brain function.
This study evaluated the effectiveness, safety, and tolerability of F-Biotic™ in patients with Type 2 Diabetes Mellitus, finding significant improvements in fasting and postprandial blood sugar levels.
This study investigated the effects of liraglutide on plasma GDF15 levels in patients with type 2 diabetes, finding no significant changes in GDF15 levels.
This Phase 2 trial evaluated the efficacy and safety of Mazdutide in Chinese patients with Type 2 Diabetes, showing significant improvements in glycemic control and weight loss.
Metformin therapy in adults with heart failure and type 2 diabetes.
This study evaluated the impact of concomitant metformin use on gastrointestinal adverse events during GLP-1 receptor agonist initiation, finding no increase in adverse events.
This post-hoc analysis of the SURPASS-4 trial compared tirzepatide to insulin glargine in participants with type 2 diabetes, finding significant reductions in HbA1c and body weight with tirzepatide.
This study analyzed the effects of Tirzepatide on individuals with early-onset Type 2 diabetes, revealing significant improvements in various health markers.
This study evaluated the efficacy and safety of adding sitagliptin to insulin treatment in patients with type 2 diabetes, finding significant reductions in HbA1c and hypoglycemia incidence.
This study compared the effects of empagliflozin and glimepiride on endothelial function in individuals with type 2 diabetes, finding no significant differences in flow-mediated dilation but notable differences in body weight and fluid volume.
This study evaluated the impact of green tea extract on glycemic and lipid profiles in patients with type 2 diabetes, finding significant improvements in several metabolic markers.
This study investigated the effects of hemodialysis on plasma glucose and liraglutide levels in patients with diabetes and end-stage renal disease, finding significant increases in maximum glucose and glycemic variability.
This study evaluated the effects of metformin delayed-release on glycemic control in adults with type 2 diabetes, showing significant reductions in HbA1c and fasting plasma glucose compared to placebo.
This study examined omentin-1 levels in patients with Type 2 Diabetes and their relationship to cardiac dysfunction, finding decreased levels linked to diastolic function.
This study compared tirzepatide and insulin lispro in patients with type 2 diabetes, finding significant improvements in health-related quality of life with tirzepatide.
This study investigated factors associated with body weight reduction in adults with Type 2 diabetes using tirzepatide, finding that higher doses led to greater weight loss.
This study compared the effects of Tirzepatide and Semaglutide on HbA1c and body weight in Hispanic or Latino patients with Type 2 Diabetes, finding significant reductions with Tirzepatide.
This study evaluated the effects of Curcuma longa extract on neuropathy symptoms and vascular biomarkers in adults with type 2 diabetes, finding significant improvements in several measures.
The study evaluated the effects of date seed powder supplementation on glycemic control and oxidative stress in type 2 diabetes patients, finding significant improvements in various metabolic markers.
This study evaluated the impact of academic detailing and group visits on prescribing practices for Type 2 Diabetes, finding significant increases in metformin and insulin prescriptions.
Semaglutide and dulaglutide administered weekly to adults with type 2 diabetes and obesity.
Daily oral supplementation of glutamine with or without sitagliptin in well-controlled type 2 diabetes patients.
The AWARD-11 trial compared the effects of Dulaglutide 3.0 mg and 4.5 mg to 1.5 mg on body weight in patients with type 2 diabetes, finding significant weight reductions.
The study evaluated the addition of liraglutide to SGLT2 inhibitors and metformin in adults with type 2 diabetes, showing significant improvements in glycaemic control.
This study evaluated the efficacy and safety of once-weekly semaglutide in Korean adults with type 2 diabetes, showing significant improvements in HbA1c and body weight.
This study compared the efficacy and safety of oral semaglutide to sitagliptin in adults with inadequately controlled type 2 diabetes. Results indicated that oral semaglutide led to significantly greater reductions in HbA1c and body weight.
This study investigated how pre-pregnancy BMI influences the effect of prebiotic supplementation on gestational diabetes mellitus (GDM) rates.
This study compared once-weekly semaglutide to thrice-daily insulin aspart in adults with type 2 diabetes, revealing significant differences in HbA1c and body weight outcomes.
This study investigated the effects of sodium butyrate supplementation on gastrointestinal symptoms in patients with type 2 diabetes and IBS, finding significant improvements in various symptoms.
This Phase II study evaluated the effects of Survodutide on HbA1c levels and bodyweight in adults with Type 2 Diabetes, finding significant reductions in both outcomes compared to baseline.
This study compared tirzepatide and dulaglutide in improving insulin sensitivity and beta-cell function in adults with type 2 diabetes, finding tirzepatide more effective.
This study investigated the effects of purified anthocyanins on vascular stiffness and cardiovascular risk in Chinese adults with dysglycemia, finding no significant improvements.
This study investigated the effects of cocoa supplementation on diabetic neuropathy in individuals with Type 2 Diabetes. Results indicated no significant differences between cocoa and placebo groups.
This study compared the effects of dapagliflozin and vitamin E in patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabetes, finding significant improvements in several metabolic parameters with dapagliflozin.
This study investigated the anti-diabetic effects of sumac in patients with type 2 diabetes, finding significant improvements in fasting blood sugar and HbA1C levels.
This study investigated the effects of Vitamin C supplementation on oxidative stress markers in patients with type 2 diabetes, finding significant reductions in malondialdehyde and advanced glycation end products.
This study investigated the effects of vitamin D3 supplementation on inflammation in type 2 diabetes patients, finding significant reductions in various inflammatory markers.
This study investigated the effects of Vitamin K4 supplementation on insulin resistance and triglyceride levels in individuals with type 2 diabetes and found significant improvements.
This study evaluated the effects of zinc gluconate and magnesium oxide as adjuncts to non-surgical periodontal treatment in patients with type 2 diabetes.
This study examined the effects of zinc supplementation on glycemic control and lipid profiles in newly diagnosed type 2 diabetes patients, finding significant reductions in fasting plasma glucose and cholesterol levels.
This study evaluated the effects of chromium supplementation on glycemic control in patients with type 2 diabetes, finding significant improvements in HbA1c and fasting plasma glucose levels.
This study evaluated the effects of Cinnamomum zeylanicum on glycemic control in individuals with type 2 diabetes, finding significant reductions in fasting plasma glucose levels.
This study investigated the effects of omega-3 and vitamin D co-supplementation on mental health and sleep quality in women with pre-diabetes and low vitamin D levels, finding significant improvements in depression, anxiety, stress, sleep quality, and vitamin D levels.
The study evaluated the effects of curcumin-piperine supplementation on oxidative stress and kidney function in diabetic retinopathy patients, finding significant improvements in antioxidant capacity and creatinine levels.
This study investigated the effects of dapagliflozin on bone metabolism in post-menopausal women with type 2 diabetes, finding significant improvements in trabecular and cortical thickness.
This study evaluated the impact of a dietary fiber supplement (YMETA) on gut health and metabolic function in prediabetic adults, finding improvements in gut microbiota diversity.
This study evaluated the effectiveness of eldecalcitol in preventing type 2 diabetes in adults with impaired glucose tolerance. It found no significant difference in diabetes incidence between eldecalcitol and placebo groups.
The ASCEND-Eye study assessed the effects of aspirin and omega-3 fatty acids on diabetic eye screening data, finding significant reductions in blood lactate and growth differentiation factor 15.
This study investigated the effects of magnesium-containing deep seawater mineral extracts on insulin resistance in patients with impaired glucose tolerance, showing improvements in several insulin-related markers.
This study examined the effects of omega-3 fatty acids as an adjunct to nonsurgical periodontal therapy in periodontitis patients with type II diabetes, finding significant improvements in various clinical parameters.
This study investigated the effects of a probiotic nutritional supplement on glycemic control in type 2 diabetes patients, revealing mixed results.
This study investigated the impact of a multi-strain probiotic supplement on various health outcomes in individuals with Type 2 diabetes, finding significant reductions in HbA1c, fasting plasma glucose, and total cholesterol.
Probiotic supplementation significantly improved insulin resistance and other metabolic markers in diabetic patients undergoing hemodialysis.
This study evaluated the effects of sitagliptin plus metformin therapy on metabolic profiles in patients with type 2 diabetes and NAFLD, finding significant improvements in various metabolic markers.
This study examined the effects of a 12-week intervention combining vitamin D supplementation and endurance exercise on bone health in patients with type 2 diabetes.
This study investigated the effects of vitamin D supplementation on inflammatory factors in patients with type 2 diabetes, finding significant reductions in certain inflammatory markers.
This randomized controlled trial investigated the effects of vitamin D supplementation on women with prediabetes, finding no significant impact on diabetes incidence or related metabolic markers.
This study evaluated the effects of canagliflozin combined with metformin on cardiovascular risk in patients with type 2 diabetes mellitus, finding a significant reduction in major adverse cardiovascular events.
The study evaluated the effects of ertugliflozin on cardiac function in individuals with type 2 diabetes and pre-heart failure, finding significant improvements in certain cardiac metrics.
This study evaluated the effects of finerenone on heart and kidney events in patients with chronic kidney disease and type 2 diabetes, finding significant reductions in event rates compared to placebo.
This study compared high-dose and standard-dose influenza vaccines in older adults with diabetes, finding that HD-IIV reduced hospitalizations for various diseases.
The J-DOIT3 trial analyzed the effects of intensified multifactorial intervention on glycemic management in type 2 diabetes, finding that intensive therapy reduced the risk of retinopathy onset.
This study investigated the effects of liraglutide on stroke recurrence in patients with type 2 diabetes, finding a lower rate of recurrence compared to the control group.
This study evaluated the effects of long-term multifactorial interventions on clinical outcomes in Emirati patients with diabetes, finding significant improvements in HbA1c and LDL-C levels.
This study evaluated the effects of oral semaglutide on cardiovascular outcomes in patients with type 2 diabetes, finding a 14% reduction in major adverse cardiovascular events compared to placebo.
Orforglipron treatment led to significant reductions in cardiovascular risk markers among participants with type 2 diabetes and obesity.
This study evaluated the cardiorenal effects of semaglutide in individuals with type 2 diabetes at high cardiovascular risk, finding significant reductions in major adverse cardiovascular events.
This study evaluated the impact of semaglutide on kidney and cardiovascular risks in individuals with type 2 diabetes and chronic kidney disease, finding significant reductions in key health outcomes.
The study evaluated the effects of semaglutide on cardiovascular events in individuals with overweight or obesity and established cardiovascular disease without diabetes, finding a 20% reduction in major adverse cardiovascular events.
This study compared the real-world effectiveness of SGLT2 inhibitors and DPP4 inhibitors in patients with type 2 diabetes and cardiovascular disease, finding that SGLT2 inhibitors were associated with lower risks of major adverse cardiovascular events.
Telehealth through SMS reminders significantly improved statin adherence and reduced cholesterol levels in patients with diabetes.
A home-based lifestyle intervention with telemedicine support showed modest effects on HbA1c levels in patients with coronary heart disease and type 2 diabetes.
This study evaluated ticagrelor monotherapy after 3 months of dual antiplatelet therapy in diabetic patients with acute coronary syndrome, finding no significant difference in major adverse cardiovascular events.
This study investigated the impact of vitamin D supplementation on fasting blood glucose levels in pregnant women with gestational diabetes, finding no significant effect on glucose levels.
This study evaluated the effects of canagliflozin on cardiovascular and kidney outcomes in individuals with type 2 diabetes, finding a reduction in major adverse cardiovascular events.
This study evaluated the impact of Clazakizumab on high-sensitivity C-reactive protein (hs-CRP) levels in patients with cardiovascular disease and diabetes, finding significant decreases in hs-CRP levels with treatment.
This study investigated the effects of dapagliflozin on cardiovascular outcomes in diabetic patients, revealing significant changes in plasma IL-1B and ketones.
This study compared the effects of empagliflozin and pioglitazone on echocardiographic indices in patients with type 2 diabetes and nonalcoholic fatty liver disease, finding significant improvements in certain measures.
This study evaluated the effects of empagliflozin on diastolic function in patients with type 2 diabetes and elevated end-diastolic pressure, finding significant improvements in various cardiovascular and metabolic parameters.
The FIGARO-DKD trial subgroup analysis evaluated finerenone in patients with type 2 diabetes and chronic kidney disease, finding significant reductions in kidney failure risk.
The study evaluated the effect of Finerenone on hypokalaemia in patients with chronic kidney disease and type 2 diabetes, finding a significant reduction in incidence compared to placebo.
The Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial demonstrated that Icosapent ethyl significantly reduced cardiovascular events compared to placebo.
This study examined the effects of intensive versus standard glycemic control on cardiovascular events in type 2 diabetes patients, finding no significant differences in certain outcomes.
This study analyzed the effects of Multifactorial Therapy (MT) versus Usual Care (UC) in participants with type 2 diabetes, finding significant reductions in major adverse cardiovascular events and all-cause mortality.
The study evaluated the effects of semaglutide on vascular regenerative cell content in individuals with type 2 diabetes, finding significant increases compared to usual care.
The FLOW trial investigated the effects of semaglutide on cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease, revealing significant reductions in cardiovascular death, myocardial infarction, and stroke.
This study evaluated the effects of SGLT2 inhibitors on cardiovascular and kidney outcomes across different levels of albuminuria. It found significant reductions in albuminuria and various adverse outcomes compared to placebo.
The study evaluated the effectiveness of the PREDIABETEXT digital health intervention for managing prediabetes. It found a nonsignificant reduction in HbA1c levels.
This study compared Family-DSMES and Standard-DSMES in participants with diabetes, finding significant improvements in diabetes-related family involvement with Family-DSMES.
This study evaluated the app-based intervention Mebix for individuals with Type 2 diabetes, finding significant improvements in HbA1c levels, weight loss, and diabetes-related distress compared to a placebo app.
This study examined the effects of a mobile health low-carbohydrate dietary application on psychosocial outcomes in individuals with Type 2 diabetes, finding improvements in perceived health status and self-efficacy.
The HAPPY Trial investigated the impact of a mobile health dietary education intervention on ultra-processed food consumption in individuals with type 2 diabetes, finding no significant effect.
This study evaluated the impact of mHealth-augmented social support on healthcare use among diabetes patients, finding reductions in acute care visits for the intervention group.
The ENERGISED trial evaluated a mobile health intervention aimed at increasing physical activity among individuals with prediabetes and type 2 diabetes.
This study evaluated the feasibility of a mobile health-supported physical activity intervention for adults with recently diagnosed Type 2 diabetes, finding high recruitment and retention rates.
The REDCHiP study aimed to reduce emotional distress in parents of children with hypoglycemia through a behavioral intervention. Results showed slight improvements in parental fear and distress, but none were statistically significant.
This study evaluated the impact of a smartphone-based intervention on medication adherence in adults with Type 2 diabetes and hypertension in Ghana, finding mixed results.
This study evaluated a telehealth intervention aimed at reducing sedentary behavior in older adults with Type 2 diabetes, finding a significant decrease in sedentary time.
This study evaluated the impact of remote insulin dose adjustment using continuous glucose monitoring (CGM) on glucose control in nursing home residents with type 2 diabetes (T2D). The intervention group showed significant improvements in glucose metrics compared to standard care.
This study evaluated the effectiveness of a telemedicine intervention for glycemic control in patients with Type 2 diabetes and found significant improvements in several key outcomes.
This study evaluated the effectiveness of telemonitoring for diabetes management in pediatric patients with type 1 diabetes. The telecounseling group showed significantly better outcomes compared to the standard care group.
This study compared a digital outdoor exercise program to a standard clinic-based exercise program in obese adults with type 2 diabetes, finding both approaches effective in improving health outcomes.
A value-based hospital-community-family linkage program improved blood glucose management in elderly patients with type 2 diabetes compared to conventional management.
This study examined the implementation of a mobile health (mHealth) intervention aimed at increasing nonexercise physical activity in patients with Type 2 Diabetes, with unclear effectiveness.
This study evaluated the effectiveness of a mobile health social support program for diabetes management in emergency department patients, finding significant improvements in HbA1c levels.
This study evaluated a mobile health intervention delivered by clinical pharmacists and health coaches to improve blood glucose levels in adults with type 2 diabetes, showing a significant reduction in Hemoglobin A1c.
This study evaluated the impact of peer-created digital storytelling videos on psychological outcomes in individuals with Type 1 diabetes. Significant improvements in diabetes distress, burnout, and depressive symptoms were observed in the intervention group.
The TELEGLAM study evaluated a telemedicine system for patients with gestational diabetes mellitus, finding significant cost reductions and improved quality of life scores compared to standard care.
The study evaluated a three-tiered linkage management model for T2DM, finding significant improvements in glycemic control and self-management.
The DiabeText study evaluated a mobile health intervention for diabetes self-management, finding significant improvements in quality of life and self-efficacy but no changes in HbA1c levels.
This study evaluated the preliminary efficacy of a digital intervention, SMART, aimed at improving metabolic health in individuals with schizophrenia spectrum disorders, showing significant improvements in various health-related outcomes.
The SuMMiT-D study evaluated a digital health intervention for diabetes management, revealing mixed perceptions of its effectiveness.
This study evaluated the Greenhabit mobile app for enhancing self-management in type 2 diabetes. Results showed significant improvements in several health metrics compared to standard care.
This study explored mobile health interventions for emerging adults with Type 1 diabetes, finding them acceptable and relevant.
This study evaluated the effectiveness of an online low glycemic index diet for managing type 2 diabetes, showing significant improvements in several health markers.
This study compared diabetes self-management education via telemedicine to face-to-face encounters, finding significant improvements in glycemic control and diabetes knowledge.
This study evaluated the effectiveness of a diabetes app for blood glucose control in patients with type 2 diabetes. It found that while the app did not significantly improve HbA1c or BMI, it was associated with lower systolic blood pressure and high participant satisfaction.
This study evaluated a digital education platform for diabetes management against conventional outpatient education, finding significant improvements in HbA1c and treatment satisfaction.
This study evaluated the efficacy of a digital educational intervention for patients with Type 2 diabetes, finding significant improvements in various health metrics.
This study explored a digital intervention for emerging adults with Type 1 diabetes, finding improvements in diabetes knowledge and self-efficacy.
This study validated the Chinese Version of the Diabetes Health Profile Scale and assessed its impact on quality of life in Type 2 diabetes patients, finding significant differences in quality of life based on mHealth education intervention.
This study evaluated the noninferiority of the acT1ve mobile health app for managing exercise in young people with Type 1 diabetes, finding similar rates of hypoglycemia before and during app use.
This study evaluated the impact of the DialBetesPlus mobile health intervention on diabetic kidney disease, finding significant improvements in urinary albumin-to-creatinine ratio and HDL-C levels.
The REDCHiP pilot study aimed to reduce emotional distress in parents managing childhood hypoglycemia. Results indicated mixed effectiveness in applying coping strategies.
This study evaluated the impact of a smartphone-based dietary education intervention on diet quality and cardiometabolic risk markers in individuals with type 2 diabetes, revealing significant reductions in fat intake and triglyceride levels.
This study evaluated the impact of a structured food sequencing approach combined with mHealth dietary monitoring on maternal glycemic control in women with gestational diabetes mellitus, showing significant improvements in several health outcomes.
A pharmacist-driven text messaging intervention was studied to improve diabetes self-management in uninsured patients, resulting in a significant reduction in HbA1c levels.
The BRIDGE study evaluated a text messaging support program for postpartum care in women with impaired glucose tolerance, finding significant improvements in follow-up care.
This study evaluated the impact of the Vitadio digital health application on glycemic control in patients with Type 2 Diabetes Mellitus, finding significant improvements in several health metrics.
This study evaluated the effectiveness of an AI-enabled mHealth intervention for diabetes prevention in rural India, finding no significant differences in key outcomes between intervention and control groups.
This study evaluated the effectiveness of the Health Storylines mAPP for self-management among individuals with chronic illnesses in Baguio City, Philippines, finding no significant differences in self-management scores.
This study examined the impact of healthy lifestyle education on self-efficacy in patients with Type 2 diabetes, finding significant improvements in self-efficacy scores for peer education and mHealth application groups.
This study evaluated the effects of the DM2CUA mobile app on diabetes self-management in adults with Type 2 Diabetes, showing improvements in self-management and distress scores.
This study explored engagement patterns in a mobile health intervention for women at risk of gestational diabetes, revealing varied engagement clusters.
The StepAdd mobile health intervention aimed to improve physical activity in patients with Type 2 diabetes, resulting in significant increases in daily step counts.
This study evaluated the impact of the DiaCert smartphone app on physical activity levels in adults with Type 2 diabetes. Results indicated no significant improvements in moderate to vigorous physical activity or other health metrics.
This study examined the effects of smartphone applications on oral hygiene and glycemic control in diabetic patients, finding significant improvements in HbA1c levels and oral health behaviors.
This study explored participant perspectives on a comprehensive telehealth intervention for diabetes management, highlighting areas of effectiveness and improvement.
A study found that combining telephone coaching with telemedicine support significantly improved long-term glycemic control in individuals with type 2 diabetes.
This study evaluated the impact of a text messaging intervention on patient-reported outcomes in individuals with Type 2 diabetes, finding significant improvements in various health-related measures.
This study developed two automated texting systems aimed at improving diabetes self-management. Findings indicated that a significant portion of messages were rated as relevant and confidence-enhancing.
This pilot study evaluated the Type 1 Diabetes and Life (T1DAL) intervention aimed at improving health-related quality of life in individuals with Type 1 diabetes.
A study on digital coaching for obesity found significant weight loss in adults, with a decrease of 6.0 kg at 6 months compared to usual care.
This study evaluated a hybrid telemedicine approach for adults with type 1 diabetes against standard clinical practice, finding a significant reduction in HbA1c levels.
This study evaluated the effectiveness of the Remedy to Diabetes Distress (R2D2) intervention for families of children with Type 1 Diabetes, finding significant reductions in diabetes distress for parents and children.
This randomized controlled trial evaluated the impact of a mobile health intervention on diabetes self-management, revealing significant improvements in foot care and dietary behaviors.
This study evaluated the impact of mobile educational platforms on glycemic control in patients with nephrotic syndrome and steroid-induced diabetes mellitus, finding significant improvements in treatment adherence and blood glucose levels.
This pilot randomized controlled trial evaluated the feasibility of using SMS messaging to enhance medication adherence in individuals with Type 2 diabetes.
This study evaluated the impact of a telehealth intervention on metabolic outcomes in diabetes patients during the COVID-19 pandemic, finding no significant changes in most outcomes except for triglyceride levels in type 1 diabetes patients.
The MODEL Study evaluated patient-centered behavioral interventions for diabetes self-care, finding significant improvements in healthy eating days and HbA1c levels.
This study evaluated a text messaging-based lifestyle support program for women with gestational diabetes. Results showed no significant differences in key health outcomes compared to a control group.
This study evaluated a training program for telehealth coaches managing Type 2 Diabetes and Coronary Heart Disease, finding positive feedback on training effectiveness.
This study investigated the effects of Vitamin D3 supplementation alongside scaling and root planing in patients with Type 2 Diabetes Mellitus and periodontitis, finding significant improvements in periodontal health indicators.
This study explored a digital health intervention aimed at women with gestational diabetes in Vietnam, focusing on various health outcomes.
The VA|PREVENTION project aimed to prevent type 2 diabetes in high-risk adults using a digital intervention. Participants showed improvements in walking and dietary behaviors.
This study evaluated the effects of extra virgin olive oil supplementation in women with gestational diabetes, finding significant reductions in insulin requirements and neonatal complications.
The Finerenone Trial investigated the efficacy and safety of finerenone compared to placebo in patients with heart failure, demonstrating significant benefits.
This study evaluated two health education apps for diabetes management, finding varying levels of user satisfaction and knowledge improvement.
This study evaluated the effects of oral multivitamins and multiminerals (OMVM) in patients with diabetes and a history of myocardial infarction. The findings indicated no significant differences in major cardiovascular outcomes between the OMVM and placebo groups.
This study examined the effects of an adaptive mobile health texting intervention on patient-provider communication ratings. Results indicated a nonsignificant decrease in CAHPS scores over six months.
The ASCEND PLUS trial evaluated oral semaglutide for preventing cardiovascular events in type 2 diabetes but found no significant benefits.
This study evaluated the efficacy of Sarcomeal supplement and vitamin D3 on muscle parameters in diabetic sarcopenia patients, revealing significant improvements in lean body mass and lean mass index.
This study evaluated the effectiveness of scalable diabetes self-management education and support models in adults with Type 2 Diabetes. Results showed no significant changes in key health outcomes.
The study evaluated semaglutide, a glucagon-like peptide-1 receptor agonist, for managing high cardiovascular risk and found significant reductions in major renal events and cardiovascular risks.
This study investigated the effects of long-term bilberry and grape seed extract supplementation on blood pressure in individuals at risk of type 2 diabetes mellitus (T2DM). It found significant reductions in systolic and diastolic blood pressure.
CHW-led diabetes care with monthly group visits and weekly mHealth contact in uninsured adults with type 2 diabetes.
Citrulline supplementation improved microvascular function and muscle strength in patients with type 2 diabetes compared to placebo.
Mobile phone-based app with or without telehealth counseling in adults with type 2 diabetes.
This study compared the effectiveness of Vitadio digital therapy and an intensive in-person weight loss program. Both interventions resulted in significant weight loss and improvements in various health metrics.
A family-oriented mHealth intervention including 24 videos on T2D self-management and behavioral techniques.
This study investigated the effects of GLP-1 receptor agonists, liraglutide and semaglutide, on cardiovascular outcomes in diabetes, finding significant reductions in major adverse cardiovascular events.
The study evaluated the impact of lixisenatide on aortic pulse wave velocity in patients with CKD and type 2 diabetes, finding no significant changes.
A blend of mulberry leaf extract, fiber, vitamin D, and chromium in adults with type 2 diabetes.
This pilot study evaluated a mobile insulin titration intervention for transitioning patients with Type 2 Diabetes from basal insulin to GLP-1 receptor agonists, showing promising outcomes.
This study investigated the effects of lavender aromatherapy and virtual reality on sleep quality in patients with type 2 diabetes, finding significant improvements in both interventions.
This study investigated the effects of auricular acupressure on sleep quality and blood glucose levels in elderly individuals with type 2 diabetes, finding significant improvements in both areas.
This study evaluated a concentrated transdiagnostic treatment for patients with Type 2 diabetes and sleep disorders, showing significant improvements in sleep-related outcomes over 12 months.
This study explored factors influencing engagement with the i-Matter mHealth tool for diabetes self-management, highlighting its impact on patient attitudes and engagement.
This qualitative study explored the experiences of rural caregivers managing children with Type 1 Diabetes, highlighting their challenges and support needs.
This study evaluated the effectiveness of two behavioral interventions aimed at improving medication adherence in adults with Type 2 diabetes.
This study examined the impact of progressive relaxation exercises on fatigue and sleep issues in individuals with type 2 diabetes, revealing significant improvements in fatigue levels.
This study investigated the impact of telehealth monitoring and patient training on symptoms and metabolic outcomes in type 2 diabetes patients at risk of COVID-19, finding significant improvements in various symptoms.
This study evaluated the impact of telemedicine-assisted structured self-monitoring of blood glucose on glycemic control in adults with type 2 diabetes, finding significant improvements in HbA1c and other metrics.
This study evaluated the impact of Cognitive Behavioral Therapy for Insomnia (CBTI) on sleep regularity and anxiety in individuals with Type 2 Diabetes. CBTI showed significant improvements in sleep regularity and anxiety symptoms compared to Health Education (HE).
This study examined the impact of integrating continuous glucose monitoring into individualized nutrition therapy on dietary habits and sleep quality in individuals with prediabetes and obesity. Significant improvements were observed in whole-grain intake, plant-based protein intake, and sleep efficiency.
The study evaluated the Complete Health Improvement Program (CHIP) against usual care in a randomized-controlled trial. Results indicated improvements in HbA1c and waist circumference for the intervention group.
A comprehensive exercise program significantly improved sleep quality and various health markers in adults with type 2 diabetes.
This study evaluated the Fos Biomedical non-transdermal patch system's effects on cardio-metabolic health and sleep quality, finding no significant improvements in key outcomes.
This study investigated the effects of Lactobacillus johnsonii supplementation on blood glucose control in individuals with Type 2 Diabetes and circadian rhythm disruption, finding significant improvements in several metabolic parameters.
This study evaluated robotic surgical strategies for managing Type 2 diabetes, showing promising outcomes in weight loss and insulin reduction.
This study examined the effects of time-restricted eating on sleep in adults with type 2 diabetes and found no significant impact on sleep quality or duration.
The Women’s Wellness with Type 2 Diabetes Programme (WWDP+) was found to be acceptable and feasible for midlife women, demonstrating significant improvements in various health outcomes.
The study evaluated the impact of automated insulin delivery on glycaemia and sleep in young people with type 1 diabetes, finding significant improvements in HbA1c but negative effects on sleep.
A study found that supervised home-based elastic band exercises significantly improved health outcomes in pre-frail older adults with type 2 diabetes.
This study evaluated an educational intervention aimed at improving sleep hygiene in patients with type 2 diabetes, showing significant improvements in sleep quality and metabolic markers at 3 months.
This study evaluated the impact of light therapy on sleep quality and circadian rhythm in older adults with type 2 diabetes, finding significant improvements in sleep quality.
This study investigated the effects of liraglutide combined with CPAP on patients with Type 2 diabetes and severe obstructive sleep apnea, finding significant improvements in several health metrics.
This study evaluated the effects of a multi-disciplinary team nursing model combined with high-fiber dietary intervention on elderly diabetes patients, finding significant improvements in various health outcomes.
This study investigated the effects of circuit resistance training, a vegetarian/Mediterranean diet, and empagliflozin on resting metabolic rate in older adults with type 2 diabetes, finding no significant differences in resting metabolic rate across groups.
This study examined the impact of a nursing approach based on the PRECEDE-PROCEED model on health behaviors and sleep quality in women with gestational diabetes, finding significant improvements in various health metrics.
This study evaluated the effects of Cognitive Behavioral Therapy and Mindfulness-Based Stress Reduction on patients with diabetes and endometrial cancer, finding significant improvements in mood and sleep quality.
This study evaluated the effectiveness of Cognitive Behavioral Therapy (CBT) for Type 2 diabetes patients with metabolic syndrome, showing significant improvements in depression and self-management behaviors.
This study compared closed-loop therapy with CSII + CGM in individuals with type 2 diabetes, finding that closed-loop therapy significantly improved glycemic control.
This study evaluated the use of Consumer Sleep Trackers (CSTs) with coaching in behavioral sleep extension studies, finding high adherence and retention rates.
This study investigated the effects of Continuous Positive Airway Pressure (CPAP) treatment on blood glucose levels in patients with type 2 diabetes and obstructive sleep apnea, finding significant improvements in various glucose metrics.
A study on liraglutide 3 mg demonstrated significant weight loss in adults with obesity compared to a control group.
This study evaluated the impact of a Mediterranean diet on daytime sleepiness in individuals with Type 2 Diabetes in Oman, finding significant improvements in the intervention group.
This study evaluated the effects of Melissa officinalis extract on depression and anxiety in patients with type 2 diabetes, finding significant reductions in both conditions.
This study evaluated the efficacy of Suvorexant in improving sleep and health outcomes in individuals with Type 2 diabetes and insomnia, finding no significant improvements.
This study evaluated the impact of hybrid closed-loop insulin delivery on sleep in young people newly diagnosed with type 1 diabetes and their parents, finding no significant differences in sleep outcomes compared to standard care.
This study investigated the impact of CPAP therapy on glycaemic control in patients with type 2 diabetes and obstructive sleep apnoea, finding no significant changes in most glucose metrics.
This study examined the impact of the DASH diet on sleep, mental health, and hormonal changes in Iranian women with Type 2 diabetes, revealing significant improvements in several health metrics.
This study investigated the impact of a regular exercise program on sleep habits in children with Type 1 Diabetes, revealing significant improvements in various sleep-related outcomes.
This study examined the impact of an Integrative Complementary Medicine (ICM) program on the quality of life in cancer patients with diabetes, revealing significant differences in drowsiness and emotional functioning.
A 12-week laughter yoga program was found to be feasible for individuals with type 2 diabetes and demonstrated improvements in glycemic control.
This study explored the diabetes management experiences of emerging adults with Type 1 Diabetes in rural areas, highlighting challenges and support systems.
This study evaluated the psychosocial outcomes of caregivers using the Omnipod 5 Automated Insulin Delivery System for young children with Type 1 Diabetes, finding significant improvements in several areas.
This study investigated the effects of probiotic supplementation on glycemic control in adults with type 2 diabetes. Results showed no statistically significant improvements in key glycemic markers.
This study evaluated the impact of a self-compassion intervention on diabetes distress and glycemic control in adolescents and young adults with Type 1 diabetes, finding significant improvement in HbA1c levels.
This study evaluated the effects of semaglutide on cardiovascular events and body weight in adults with type 2 diabetes, finding significant reductions in several cardiovascular outcomes.
Tirzepatide treatment significantly improved cardiometabolic risk factors in adults with obesity or overweight.
This study investigated the effects of ultrasound-guided stellate ganglion pulsed radiofrequency therapy on painful diabetic peripheral neuropathy in type 2 diabetes patients, finding significant postoperative improvements in pain and quality of life.
This study evaluated a community-based intervention for low-income adults with type 2 diabetes, finding improvements in several health metrics.
Dairy-enriched diet vs non-dairy isoenergetic diet in adults with type 2 diabetes.
Low-GI Mediterranean-style eating patterns in adults with metabolic syndrome.
This study investigated the effects of the MIND diet on cardiometabolic health in women with type 2 diabetes and insomnia, finding significant reductions in various health markers.
Electronic medical record-integrated mobile app for personalized diabetes self-care in adults with type 2 diabetes.
The IMPACT Diabetes trial evaluated a community-based intervention for diabetes care in India, finding significant improvements in HbA1c reduction and healthcare utilization.
This study evaluated the effects of colchicine on cardiovascular risk in patients with chronic coronary artery disease and diabetes, finding mixed outcomes based on diabetes status.
This study evaluated the effects of intermittent fasting on psychosomatic competence in insulin-treated patients with type 2 diabetes, finding significant weight loss in the fasting group.
This study evaluated the effect of oral semaglutide on heart failure events in patients with type 2 diabetes, finding a reduced risk of composite heart failure outcomes compared to placebo.
Probiotic supplementation was studied for its effects on glycemic control in pediatric patients with Type 1 Diabetes, showing significant improvements in several metabolic markers.
This study investigated the effects of taurine supplementation on blood pressure and vascular function in patients with type 2 diabetes, finding significant improvements in several key measures.
This pilot study evaluated the efficacy of virtual reality (VR) in improving sleep quality among patients with painful diabetic polyneuropathy. Results indicated no significant differences in sleep metrics between VR and usual care, except for a higher impression of change in patients using VR.
This study evaluated the effects of carnosine supplementation on cardiovascular and metabolic outcomes in adults with prediabetes and type 2 diabetes, finding no significant improvements.
The study evaluated the effects of DiabetEaze powder on glycaemic control and nutritional management in adults with diabetes, finding significant improvements in blood sugar levels and quality of life.
This study analyzed the relationship between insulin-like growth factor-1 (IGF-1) levels and cardiovascular outcomes in hyperglycemic acute coronary syndrome patients, finding no independent association with major adverse cardiovascular events.
MIND probiotic diet's effects on sleep quality and mental health in women with type 2 diabetes.
This study examined the effects of probiotic supplementation on β-cell function in individuals with type 2 diabetes, finding significant improvements in several metabolic parameters.
This study evaluated a synchronous telehealth exercise program's impact on adults with Type 2 diabetes, finding significant improvements in various functional outcomes.
Vitamin D3 supplementation significantly reduced infection rates and improved wound healing in patients with diabetic foot ulcers.
This study will evaluate the effects of various aerobic exercise protocols on glycemic control in patients with Type 2 Diabetes Mellitus and stroke.
This pilot study evaluated a community pharmacy-led diabetes management model using continuous glucose monitoring, finding significant improvements in HbA1c and time in range.
This study evaluated the effectiveness of buccal dextrose gel in preventing neonatal hypoglycaemia. It found that a single dose of 200 mg/kg dextrose gel significantly reduced the incidence of hypoglycaemia.
This study examined the impact of hybrid closed-loop insulin therapy on insulin delivery patterns in youth with type 1 diabetes, finding a significant decrease in bolus insulin use.
This study evaluated the outcomes of intermittently scanned continuous glucose monitoring (isCGM 2.0) in children with type 1 diabetes, showing significant reductions in time below range.
This study evaluated an mHealth-based diabetes prevention program for mothers with abdominal obesity, finding significant reductions in waist circumference and diabetes risk scores.
This study evaluated a virtual diabetes care platform for young adults with type 1 diabetes, finding modest improvements in glycaemic control and reduced social burden.
This study evaluated the benefits of automated insulin delivery (AID) in adults with type 2 diabetes on GLP-1 receptor agonists, finding significant improvements in HbA1c and time-in-range.
This study evaluated culturally tailored diabetes self-management education and support with real-time continuous glucose monitoring in Latino adults with uncontrolled type 2 diabetes, finding potential benefits in HbA1c reduction.
This study evaluated the True Vie I3 Continuous Glucose Monitoring System in adults with diabetes, finding high agreement rates and minimal pain during sensor use.
This study evaluated the CamAPS FX algorithm with simplified meal announcement against carbohydrate counting in youth and young adults with type 1 diabetes, finding non-inferiority in glucose control.
A values-guided self-management intervention showed potential to improve glucose control in emerging adults with type 1 diabetes.
This study examined how resistance exercise timing and feeding status affect glycaemic responses in individuals with type 1 diabetes, finding significant differences in glucose levels post-exercise.
This study evaluated the efficacy and safety of bi-weekly cofrogliptin compared to daily DPP-4 inhibitors in Chinese patients with Type 2 Diabetes Mellitus.
This study evaluated the accuracy and feasibility of real-time continuous glucose monitoring (CGM) in early postoperative intensive care after liver transplantation.
This study evaluated the feasibility of continuous glucose monitoring (CGM) in a rural population with type 1 diabetes, finding no significant change in HbA1c levels.
This study evaluated a decision support system for insulin dosing in adults with type 1 diabetes, finding a significant reduction in HbA1c levels.
The study evaluated the effects of empagliflozin on glycemic control in adults with HNF1A-MODY, finding significant reductions in glucose levels and improvements in time in range.
This study compared the Equil patch insulin pump and the Medtronic MMT-712 insulin pump in treating Type 2 diabetes, finding no significant differences in key outcomes.
This study compared diabetes-specific psychological outcomes in adults with type 1 diabetes using hybrid closed-loop therapy versus standard therapy, finding that the hybrid approach led to improved well-being and reduced distress.
This study analyzed insulin requirements in children and adolescents with Type 1 Diabetes using a closed-loop insulin delivery system. It found significant increases in total daily insulin doses and the proportion of basal insulin over 48 months.
This study examined pregnancy and post-delivery outcomes in women with type 1 diabetes using non-automated insulin pumps versus multiple daily injections. It found higher rates of preterm delivery and caesarean sections associated with insulin pumps.
This study compared the efficacy and safety of mulberry twig alkaloids (SZ-A) to canagliflozin in individuals with poorly controlled type 2 diabetes, finding both treatments effective in reducing key glucose metrics.
This study evaluated the effects of premeal versus postmeal metformin administration on postmeal glycemic control, finding that premeal administration was more effective.
The study evaluated the impact of the SNAQ meal analysis app on glucose control in adults with type 1 diabetes using automated insulin delivery (AID) systems.
This study explored participants' experiences with a telemonitoring intervention for Type 2 Diabetes, finding high satisfaction and improved lifestyle behaviors.
The study investigated the experiences of youth with Type 1 diabetes starting advanced hybrid closed-loop therapy, revealing significant improvements in HbA1c and overall satisfaction.
This study evaluated the impact of continuous glucose monitoring (CGM) on glycaemic control in patients with chronic pancreatitis and insulin-treated diabetes, finding significant improvements in time in range.
This study evaluated the addition of dapagliflozin to insulin pump therapy in patients with Type 2 diabetes, finding significant improvements in glycemic targets and insulin dosage.
The study found that real-world use of Dexcom ONE CGM led to significant reductions in mean HbA1c levels after 6 months.
The study evaluated the impact of iGlarLixi on treatment satisfaction in adults with Type 2 Diabetes, showing improvements in satisfaction scores and time in range.
The Diabself-care Program, a nurse-led diabetes self-management intervention, significantly improved self-management adherence and reduced anxiety and depression scores in participants.
This study examined the effects of short-term carbohydrate restriction on insulin requirements and the IGF axis in adults with type 1 diabetes, finding significant differences in IGF-1 levels between diets.
This study evaluated the impact of Flash Glucose Monitoring (FGM) on glycaemic control in youth with Type 1 Diabetes in India, finding significant reductions in HbA1c levels compared to self-monitoring.
Traditional lifestyle interventions, including low carbohydrate and Mediterranean diets, showed improvements in continuous glucose monitoring metrics within four days.
This study evaluated the impact of sitagliptin on diabetic nephropathy in adolescents with type 1 diabetes, finding significant improvements in several metabolic parameters.
This study evaluated the effectiveness of smart insulin dosage software versus traditional physician experience in managing hyperglycemia in T2DM patients receiving insulin treatment, finding significant advantages for the software.
Switching from DPP-4 inhibitors to oral semaglutide improved oxidative stress and glycemic parameters in patients with type 2 diabetes.
This study evaluated ultra-rapid insulin lispro (URIL) compared to standard insulin lispro (IL) in closed-loop systems for type 1 diabetes, finding URIL improved glucose control metrics.
This study evaluated the effects of adjunctive vildagliptin therapy during Ramadan fasting in adolescents and young adults with type 1 diabetes, finding significant improvements in glucose management.
This study compared the effects of acarbose and sitagliptin, both added to metformin, on glycemic variability in type 2 diabetes patients.
Baseline habitual physical activity's effect on glycemic responses to exercise in older adults with type 2 diabetes.
This study evaluated the effects of a digital diabetes self-management education program combined with continuous glucose monitoring on glycemic control in adults with type 2 diabetes. The intervention group showed significant improvements in several glycemic outcomes compared to usual care.
Multidisciplinary hybrid education integrated with continuous glucose monitoring in adults with type 1 diabetes.
Glunovo probiotic added to metformin in adults with type 2 diabetes.
The study investigated the impact of semaglutide on insulin needs in individuals with type 1 diabetes using pump therapy, revealing significant reductions in insulin requirements.
Video consultations compared to physical consultations in adults with type 1 diabetes.
This study evaluated two advanced insulin dosing algorithms for managing postprandial glucose levels in adolescents with Type 1 Diabetes, finding significant differences in glucose levels but no impact on hypoglycemic episodes.
AndroidAPS, an open-source automated delivery system, in adults with type 1 diabetes.
Automated insulin-glucagon delivery system compared to automated insulin delivery in adults with type 1 diabetes.
FLO23011, a novel glucose and beta-hydroxybutyrate combination, in adults with type 1 diabetes.
This study evaluated an open-source hybrid closed-loop automated insulin delivery system in perioperative patients with Type 2 diabetes, finding it significantly improved glucose control compared to conventional insulin pump therapy.
This study evaluated the effects of semaglutide on glycemic control in adults with Type 1 diabetes using automated insulin delivery. Semaglutide improved the percentage of time spent in the target glucose range significantly.
This study evaluated the impact of switching from self-monitoring of blood glucose (SMBG) to continuous glucose monitoring (CGM) in adults with Type 1 diabetes, finding significant improvements in glycaemic quality.
This study evaluated the efficacy and safety of the Tubeless Omnipod 5 automated insulin delivery system compared to traditional pump therapy with continuous glucose monitoring in adults with Type 1 diabetes.
The DIREM Study evaluated the effects of different dietary interventions on diabetes remission. Results showed higher remission rates in the calorie-carbohydrate restriction and intermittent fasting groups compared to usual care.
This study characterized continuous glucose monitoring data in patients with Type 2 diabetes in China, revealing associations between glycemic metrics and various factors.
This study explored barriers and facilitators affecting weight loss behavior in obese individuals with early Type 2 diabetes, finding an average weight loss of 6.7 kg after a Very Low Calorie Diet.
This study evaluated the use of insulin degludec and insulin aspart guided by a clinical decision support system for glycemic control in hospitalized patients with type 2 diabetes, finding a significant percentage of blood glucose measurements within target range.
This study investigated the effects of intensive lifestyle modifications on psychological health in adults with Type 2 diabetes, finding significant reductions in diabetes-related distress.
This study investigated the effects of a short-term ketogenic diet on the gut microbiome in severely obese, prediabetic patients, revealing significant changes in microbiota composition.
This pilot study investigated the effects of time-restricted eating on individuals with type 2 diabetes, revealing significant improvements in 1,5-Anhydroglucitol levels and hypoglycemia symptom recognition.
This study compared the effects of pharmacological treatment, bariatric surgery, and a very-low-calorie diet on insulin resistance in patients with type 2 diabetes and hypertension, finding significant improvements in insulin resistance and weight loss with surgery and diet.
This study investigated the effects of bariatric surgery on gut microbiota and type 2 diabetes remission, finding that Roux-en-Y gastric bypass (RYGB) led to greater weight loss and higher diabetes remission rates compared to sleeve gastrectomy (SG).
This study investigated the effects of intermittent fasting on glycaemic control and weight management in insulin-treated type 2 diabetes, finding significant improvements in the fasting group.
A study found that a 12-hour intermittent fasting regimen combined with calorie restriction led to greater weight loss and improved glycemic control in type 2 diabetes patients compared to calorie restriction alone.
This study evaluated the impact of a prepregnancy lifestyle intervention on glucose tolerance in individuals at higher risk for gestational diabetes. The intervention did not significantly affect glucose levels.
The REPAIR trial investigated the effects of a plant-based lifestyle intervention on diabetes remission and weight loss. Results showed no significant differences compared to standard care.
This study evaluated the impact of a preconception lifestyle intervention on neonatal outcomes, finding no significant differences between intervention and control groups.
This study examined the effects of a carbohydrate-reduced high-protein diet versus a conventional diabetes diet on glycemic control and liver fat in individuals with type 2 diabetes.
This study examined the long-term effects of the Tübingen Lifestyle Intervention Program on glycemia and insulin secretion in individuals at high risk for type 2 diabetes, revealing significant increases in fasting plasma glucose and 2-hour plasma glucose levels among certain participants.
This study investigated the anti-aging effects of Henagliflozin in patients with Type 2 diabetes, finding an increase in telomere length and other biomarkers.
This study evaluated a homemade very low calorie diet for weight loss in obese individuals with prediabetes or early onset type 2 diabetes, showing significant weight loss and improvements in several health markers.
Structured lifestyle modification counseling significantly improved weight and BMI in adults with type 2 diabetes compared to routine clinical care.
This study compared Long Biliopancreatic Limb Roux-en-Y Gastric Bypass (BPL-RYGB) to Long Alimentary Limb Roux-en-Y Gastric Bypass (AL-RYGB) in adults with obesity and Type 2 diabetes, finding a greater decrease in HbA1c with BPL-RYGB.
This study evaluated the effectiveness of a very low-calorie diet (VLCD) in newly diagnosed type 2 diabetes patients, finding significant improvements in insulin resistance and other metabolic markers.
This study explored a time-restricted eating intervention for women with overweight/obesity and HIV in South Africa, finding positive outcomes in energy, appetite control, and weight loss.
This study examined the effects of time-restricted eating on mood and quality of life in adults with type 2 diabetes, finding significant weight loss in the TRE group.
This study evaluated the efficacy of Resmetirom in patients with metabolic dysfunction associated steatohepatitis and type 2 diabetes, finding significant improvements in liver health outcomes.
This study evaluated the effects of adding empagliflozin, pioglitazone, or glimepiride to metformin and DPP-4 inhibitors in patients with type 2 diabetes, showing improvements in glycemic control.
This study evaluated the effectiveness of a digital habit formation app combined with a standard lifestyle change program for diabetes prevention. It found improved retention rates and significant weight loss at 12 months.
This study investigated how baseline insulin resistance affects exercise-induced changes in immune-inflammation and metabolic parameters in individuals with Type 2 Diabetes.
This study investigated the effects of intermittent fasting strategies on weight loss and insulin resistance in night shift workers, finding no significant differences in body weight or insulin resistance compared to continuous energy restriction.
This study evaluated the effects of tofogliflozin on patients with type 2 diabetes and obesity, finding significant improvements in weight loss and metabolic parameters.
This study evaluated the effects of Vildagliptin on insulin resistance and weight reduction in newly diagnosed Type 2 Diabetes patients, showing significant improvements in several metabolic parameters.
This study compared the effectiveness of Roux-en-Y gastric bypass (RYGB) and a very low-calorie diet (VLCD) in individuals with obesity, finding no significant differences in weight loss outcomes.
This study evaluated the effects of caloric restriction with or without exercise on fat mass in adults with type 2 diabetes, finding significant reductions in fat mass percentage.
A structured calorie-restricted dietary intervention improved weight loss and glycemic response in adults with Type 2 diabetes.
This study investigated the effects of intermittent fasting on HDL functionality in individuals with type 2 diabetes, finding significant increases in serum apoM levels with intermittent fasting.
This study investigated the effects of a 16-week intermittent fasting meal replacement diet on glycemic control in adults with type 2 diabetes, finding significant reductions in HbA1c and body weight.
This Phase III trial compared Liraglutide Biosimilar with reference Liraglutide, finding both effective in reducing body weight and improving glycemic control.
This study evaluated the efficacy of once-daily oral semaglutide 25 mg in adults with obesity and type 2 diabetes, finding significant weight reduction compared to placebo.
This study analyzed the effects of tirzepatide on metabolic dysfunction-associated steatohepatitis (MASH) in participants from the SYNERGY-NASH trial, revealing significant improvements in body weight and HbA1c levels.
A 3-month aerobic cycling program significantly improved metabolic health and quality of life in middle-aged men with type 2 diabetes.
Bariatric surgery significantly reduced cardiovascular disease risk factors in Emirati individuals with type 2 diabetes.
An interdisciplinary obesity care approach led to significant weight loss and improved diabetes control over 2 years compared to usual care.
This study investigated the effects of semaglutide on weight loss in adults with metabolic dysfunction-associated steatotic liver disease. Semaglutide led to a significant weight reduction compared to placebo.
This study investigated the effects of structured exercise programs on glucose metabolism and weight loss in participants after Roux-en-Y gastric bypass, finding significant weight and fat mass reductions.
This study evaluated the effects of time-restricted feeding on glycaemic regulation and weight changes in overweight patients with type 2 diabetes, finding significant improvements in various health markers.
A behavioral weight management program combined with dietary counseling did not improve HbA1c levels in participants with type 2 diabetes over 12 months.
Dapagliflozin demonstrated significant improvements in key health markers in participants with Type 2 Diabetes Mellitus.
This study examined the effects of Early Time-Restricted Eating combined with Daily Caloric Restriction on glucose levels in adults with overweight or obesity, finding a lower day-night sensor ratio in the E-TRE+DCR group.
Ebenatide treatment significantly improved glycemic control and body composition in participants with Type 2 Diabetes Mellitus over 52 weeks.
This study compared once-weekly efsitora to once-daily degludec in reducing HbA1c levels in Japanese adults with type 2 diabetes, finding comparable efficacy.
This study investigated the impact of fatty fish consumption on plasma CMPF concentration and glucose metabolism in individuals with impaired glucose metabolism. Results indicated that increased fish consumption did not correlate with impaired glucose metabolism.
This study investigated the effects of intermittent fasting on glycemic control in adults with type 2 diabetes, finding significant improvements in several metabolic markers.
This study evaluated the effects of intermittent fasting and caloric restriction on type 2 diabetes risk parameters. Results indicated unclear effectiveness on HOMA-IR and fasting glucose improvement.
This study evaluated the hypoglycemic effects of topical Citrullus colocynthis fruit extract in individuals with type 2 diabetes, showing significant blood glucose reduction without adverse effects.
The study evaluated a Therapeutic Yoga Module (TYM) aimed at improving glycemic control in individuals with impaired fasting glucose, showing significant reductions in fasting blood glucose and HbA1c levels.
This study evaluated the efficacy and safety of a fixed-dose combination of dapagliflozin and pioglitazone in patients with type 2 diabetes inadequately controlled on metformin. The findings suggested that while both treatments reduced HbA1c, the fixed-dose combination had a higher rate of adverse events.
This study evaluated the effectiveness of a Family Health Nurse model on diabetes self-management in middle-aged women, finding significant improvements in self-management scores and reductions in HbA1c levels.
This study evaluated the efficacy of fermented deglycyrrhizinated licorice (FDGL) in treating early-stage diabetic polyneuropathy, showing significant improvements in nerve conduction velocities and vibration perception.
This study evaluated the impact of receptive music therapy combined with usual nursing care on cognitive performance and quality of life in elderly patients with type 2 diabetes.
Topical ozonated olive oil significantly improved wound healing and quality of life in diabetic foot ulcer patients compared to standard care.
A quinoa-based dietary intervention improved glycemic control in patients with early-stage type 2 diabetes mellitus.
This study evaluated the efficacy and safety of a triple fixed-dose combination of sitagliptin, metformin, and glimepiride in Indian patients with uncontrolled Type 2 diabetes, finding significant reductions in HbA1c levels.
This study evaluated the effectiveness of a triple fixed-dose combination of Dapagliflozin, Sitagliptin, and Metformin compared to a dual combination of Sitagliptin and Metformin in managing Type 2 Diabetes.
This study explored a video game intervention aimed at enhancing diabetes-related numeracy but found no long-term benefits.
This study evaluated the effects of empagliflozin as an adjunct to insulin in patients with type 1 diabetes, showing significant reductions in blood sugar levels and insulin doses.
This study evaluated the effectiveness of β-glucan-enriched bread on glycemic control in adults at risk of type 2 diabetes, finding no significant differences in key outcomes.
This study investigated the effect of metformin on insulin requirements in pregnant women with type 1 diabetes, finding a significant reduction in prandial insulin needs.
This study evaluated the impact of nurse-led diabetic follow-up clinics on glycemic control in Type 2 diabetes patients, finding significant improvements in HbA1c levels and treatment satisfaction.
Orem’s Self-Care Model-based program improved glycemic control and psychosocial self-care in Palestinian children with T1DM.
This study explored the impact of non-surgical periodontal therapy on glycemic control in individuals with type 2 diabetes and periodontitis, finding a significant reduction in HbA1c levels.
This study evaluated the impact of an interactive virtual assistant device on mental health and diabetes management in older adults with diabetes, finding significant improvements in several outcomes.
The study investigated the addition of vildagliptin to premixed insulin therapy in patients with type 2 diabetes, finding significant improvements in glycemic control.
This study evaluated the effectiveness of two automated systems for assessing care quality in type 2 diabetes management, finding high completeness and correctness in system comments.
The study evaluated CT-868, a dual GLP-1/GIP receptor agonist, and found it significantly improved glycaemic control in adults with type 2 diabetes.
This randomized clinical trial assessed the impact of various dietary interventions on glycemic control in pre-diabetic patients, finding significant reductions in body weight, fasting blood sugar, and hemoglobin A1c.
This study investigated the pharmacodynamic properties of insulin analogs detemir and glargine in severely obese patients with type 2 diabetes, revealing significant increases in glucose infusion rates.
This study evaluated the efficacy and safety of imeglimin as an add-on therapy to DPP-4 inhibitors in patients with type 2 diabetes, showing mixed results in glycemic control.
This study investigated the effects of short-term hyperglycemia from insulin discontinuation on myocardial contractile function in type 2 diabetic patients, finding significant improvements in several cardiac metrics.
This study compared Time-Restricted Eating (TRE) and Daily Calorie Restriction (CR) for weight loss in adults with Type 2 Diabetes, finding TRE to be more effective.
This study evaluated an AI-based insulin decision support system against standard therapy by senior endocrinologists for managing Type 2 diabetes. The AI system showed comparable glycemic outcomes.
The study evaluated the efficacy of Boscisucrophage in patients with Type 2 Diabetes who were resistant to oral antihyperglycemic drugs, finding significant reductions in fasting plasma glucose and HbA1c levels.
This study evaluated the effects of combining oral hypoglycemic agents with short-term intensive insulin therapy in newly diagnosed type 2 diabetes patients, finding improved glycemic outcomes with combination treatments.
This study evaluated the efficacy of a dynamic algorithm for intravenous insulin therapy compared to a static protocol in non-critically ill patients, finding significant improvements in glycaemic control.
This study evaluated a health literacy-adapted educational intervention for patients with Type 2 Diabetes Mellitus, finding significant improvements in various health metrics.
This study evaluated the impact of hypoglycemic agents combined with a high protein diet and moderate exercise on diabetes remission rates.
This study examined the effects of Naltrexone/Bupropion on hepatic health in patients with Type 2 diabetes and obesity, finding significant improvements in hepatic steatosis and fibrosis markers.
This study investigated the impact of non-surgical periodontal therapy on renal function and glycaemic control in chronic kidney disease patients, finding significant improvements in eGFR and HbA1c levels.
Polyethylene glycol loxenatide (PEG-Loxe) for weight reduction and metabolic improvement in super-obese patients with type 2 diabetes.
This study investigated the effects of a reduced-energy diet during pregnancy on maternal glycaemia in women with gestational diabetes, finding no significant differences in maternal weight change or offspring birth weight between diet groups.
This study compared long-term outcomes of laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass in patients with type 2 diabetes and obesity, revealing significant differences in anxiety and physical health scores.
Daily oral supplementation with A. soehngenii improved glycemic control in prediabetic adults compared to placebo.
This study compared the acute effects of aerobic and resistance exercise on blood glucose levels in individuals with type 2 diabetes, finding similar reductions in HbA1c for both interventions.
This study evaluated a cloud-based platform for developing algorithms for type 1 diabetes using various artificial pancreas systems. It found slight improvements in glucose management metrics.
This study investigated the effects of concurrent training and microencapsulated polyphenol supplementation on glycemic control in adults with prediabetes, finding significant improvements in several health markers.
This study evaluated the efficacy and safety of dapagliflozin combined with gliclazide in patients with Type 2 diabetes, finding significant reductions in HbA1c and fasting plasma glucose levels.
This study evaluated the impact of a multidisciplinary educational program on quality of life and glycemic control in children and adolescents with Type 1 Diabetes. The intervention improved adherence to carbohydrate counting but did not significantly affect quality of life or glycemic control.
A structured family and peer support intervention improved glycemic control in patients with type 2 diabetes.
This study evaluated the efficacy and safety of lobeglitazone as an add-on therapy for patients with type 2 diabetes inadequately controlled with metformin and empagliflozin, finding significant improvements in HbA1c levels.
This study evaluated the effectiveness of the Rama Diabetes Care app for managing uncontrolled Type 2 diabetes in adults. While some improvements were noted, not all findings were statistically significant.
The study evaluated the effectiveness of low-frequency self-monitoring of blood glucose in non-insulin treated type 2 diabetes patients, finding it to be sufficient and safe.
This study evaluated the efficacy and safety of a fixed-dose combination of glimepiride, voglibose, and extended-release metformin in adults with Type 2 Diabetes Mellitus, showing significant reductions in HbA1c levels.
Cyclic yoga significantly improved metabolic health markers in women with type 2 diabetes and non-alcoholic fatty liver disease compared to a control group.
This study evaluated the efficacy and safety of empagliflozin in adults with type 2 diabetes who were not adequately controlled on metformin and sitagliptin. Results indicated significant reductions in HbA1c and body weight with empagliflozin treatment.
This study evaluated the impact of financial incentives and social feedback on physical activity in adults with newly diagnosed Type 2 diabetes, finding significant increases in daily step count and physical activity levels.
This study evaluated the efficacy and safety of HD-6277, a GPR40 agonist, in adults with Type 2 diabetes, finding significant reductions in HbA1c and fasting plasma glucose.
This study evaluated the efficacy of ranolazine as an add-on therapy to metformin in patients with type 2 diabetes, finding significant improvements in glycemic control.
This study evaluated the effectiveness of an IFSMT-based self-regulation intervention in patients with Type 2 Diabetes Mellitus, finding significant improvements in self-care ability, HbA1c levels, and quality of life.
This study evaluated the effects of symbiotic capsules on glycaemic control and lipid profiles in patients with type 2 diabetes. The results indicated significant improvements in BMI, waist circumference, HDL, and fasting blood sugar levels.
This study compared the performance and patient satisfaction of the A7+TouchCare insulin patch pump with the Omnipod system, finding no significant differences in glucose management or satisfaction levels.
This study examined the effects of a dietary supplement containing cinnamon, chromium, and carnosine on fasting plasma glucose in prediabetic individuals, finding a significant reduction in fasting plasma glucose levels compared to placebo.
This study investigated the effects of essential phospholipids on liver health in patients with metabolic dysfunction-associated steatotic liver disease, finding significant improvements in hepatic steatosis and quality of life.
This study investigated the effects of inspiratory muscle loading on blood flow and glucose levels in patients with type 2 diabetes. It found that loading at 60% of PImax significantly reduced calf blood flow and increased vascular resistance.
This pilot randomized controlled trial evaluated a 12-week device-measured physical activity intervention on glycaemic control and visual functioning in individuals newly diagnosed with AGT in Ghana, finding a significant reduction in HbA1c levels.
This study evaluated the efficacy of pregabalin in treating painful diabetic peripheral neuropathy. Higher doses of pregabalin (300 mg and 600 mg) significantly reduced pain scores compared to placebo.
This study investigated the impact of resistant starch on insulin secretion in overweight individuals with insulin resistance, finding a significant increase in insulin response with resistant starch compared to placebo.
This Phase 2 trial evaluated tirzepatide in adults with type 1 diabetes and obesity, showing significant weight loss and insulin dose reduction.
This study evaluated a culture-specific behavior modification program for adults with diabetes and hypertension, finding significant reductions in HbA1c and blood pressure.
This study investigated endovascular denervation targeting the celiac and hepatic arteries in patients with poorly controlled type 2 diabetes, finding significant reductions in HbA1c levels.
A 12-week personalized exercise and self-management program significantly reduced systolic blood pressure in individuals with multimorbidity.
This study compared a functional medicine approach to usual care in insulin-dependent type 2 diabetes, finding no significant differences in key outcomes.
This study compared the effects of a Low Glycemic Load Diet and a Conventional Energy-Restricted Diet on central obesity and lipid profiles in newly diagnosed type 2 diabetes patients.
This study evaluated the effects of qigong and tai chi on middle-aged and older adults with type 2 diabetes mellitus (T2DM). Tai chi significantly increased HbA1C levels and reduced C-Peptide levels compared to the control group.
This study evaluated the short-term effects of tofogliflozin on insulin secretory capacity in type 2 diabetes. It found significant improvements in several metabolic markers.
This study evaluated the effects of therapeutic ultrasound on muscle soreness and fatigue in women with type 2 diabetes. Results indicated significant reductions in pain and fatigue levels.
This study evaluated the effects of an empowerment-based interprofessional follow-up intervention on individuals with Type 2 diabetes, finding significant improvements in glycemic control, body weight, and waist circumference.
This study evaluated the efficacy and hypoglycaemia outcomes of once-weekly insulin icodec compared to once-daily basal insulin in adults with type 2 diabetes.
This study evaluated the impact of adjunctive metformin therapy on glycemic control in overweight/obese youth with type 1 diabetes, finding no significant differences in key outcomes.
The study evaluated an mHealth-enabled hierarchical diabetes management intervention and found it improved glycemic control compared to usual care.
This study evaluated the impact of a mobile message-based intervention on cardiovascular risk factors in patients with uncontrolled type 2 diabetes, finding significant reductions in hemoglobin A1C levels.
A structured lifestyle intervention improved eating self-efficacy in patients with type 2 diabetes, particularly through the Transcultural Diabetes Nutrition Algorithm with Motivational Interviewing.
This study evaluated the efficacy of an anti-inflammatory diet combined with acupuncture in patients with type 2 diabetes and depression, finding significant reductions in depression and anxiety.
The Telemechron study will evaluate the impact of a digital platform on diabetes management among individuals with type 2 diabetes and non-ideal glycaemic values.
This study evaluated the efficacy and safety of SGLT2 and DPP-4 inhibitors in adolescents and young adults with Type 2 diabetes, finding modest reductions in HbA1c with empagliflozin.
This study examined the genetic influence of type 2 diabetes susceptibility variants on disease progression using two treatment algorithms. It found that an intensive treatment approach reduced the time to first drug prescriptions compared to conventional treatment.
This study compared the effectiveness of glycated hemoglobin measurement and oral glucose tolerance test for screening in South Asian individuals, finding higher response and participation rates for the former.
This study examined the impact of a low-carbohydrate high polyunsaturated fat diet on liver fat in individuals with type 2 diabetes, finding significant reductions in liver fat and body weight with the Healthy Nordic Diet.
This study evaluated the feasibility of a culturally adapted lifestyle intervention for preventing Type 2 diabetes in Brazil, finding significant improvements in diet quality.
This pilot study evaluated the effects of Interval Walking Training (IWT) on patients with Type 2 Diabetes, finding significant improvements in HDL-C and VO2 peak.
This study compared nonsurgical periodontal therapy with and without diode laser in type 2 diabetes patients with periodontitis, finding significant improvements in several periodontal outcomes.
This study examined the impact of magnesium deficiency on diabetes and its complications, finding significant reductions in serum calcium, urinary magnesium, cholesterol, and LDL cholesterol levels with simvastatin treatment.
A community-based nutrition education program improved metabolic and behavioral outcomes in adults with type 2 diabetes (T2D) in a low-resource setting.
This study evaluated the impact of non-surgical periodontal therapy on glycemic control in patients with type 2 diabetes, finding significant improvements in periodontal health but no significant change in HbA1c levels.
The study evaluated the QCC nursing model's impact on blood glucose control in Type 2 diabetes patients, finding significant improvements in various metabolic markers.
This study investigated the impact of subgingival scaling and root planing (SRP) combined with oral hygiene instruction (OHI) on glycemic control in type 2 diabetes patients with periodontitis, finding significant improvements in certain clinical measures.
This study evaluated a telecare-enhanced hybrid consultation model for diabetes management, finding comparable HbA1c levels but improved blood pressure in the intervention group.
This study evaluated the effects of adjunctive antimicrobial photodynamic therapy (aPDT) on periodontal health in patients with type 1 diabetes. It found significant reductions in probing depth and TNF-α levels.
This study evaluated how baseline characteristics and metabolomic features can predict the effectiveness of exenatide in lowering glucose levels in patients with type 2 diabetes mellitus (T2DM).
This study evaluated the efficacy of a diabetes-specific formula-based partial meal replacement in adults with Type 2 diabetes, finding significant improvements in HbA1c levels.
This study evaluated a digital educational intervention based on Orem's Self-Care Theory for patients with Type 2 diabetes, finding significant improvements in self-care behaviors, self-efficacy, and HbA1c levels.
This study evaluated the outcomes of endoscopic partial jejunal diversion using a self-assembling magnetic anastomosis system over 36 months, finding significant weight loss and improvements in glycemic control.
This pilot randomized controlled trial evaluated flash glucose monitoring in Indigenous Australians with type 2 diabetes, finding no significant differences in key outcomes.
This study evaluated the efficacy of gaseous ozone therapy combined with non-surgical periodontal treatment in diabetic patients. Both treatment approaches showed effectiveness in improving clinical parameters.
This study compared the effects of combined aerobic-resistance training and high-intensity interval training on adults with type 2 diabetes. Both interventions showed significant improvements in fasting insulin and HbA1c levels compared to standard care.
This study evaluated the effects of Berberine Ursodeoxycholate (HTD1801) on type 2 diabetes management. Results indicated significant reductions in HbA1c and fasting plasma glucose levels.
This study evaluated the efficacy of hyaluronic acid in non-surgical periodontal treatment for patients with type 2 diabetes, finding it reduced bleeding on probing and clinical attachment levels compared to a placebo.
This study explored the effects of an intensive lifestyle intervention on a patient with type 2 diabetes and nephrectomy, resulting in significant health improvements.
This study investigated the effects of periodontal treatment on the risk of cerebral infarction in patients with type 2 diabetes mellitus, finding significant reductions in inflammatory markers.
This study evaluated the efficacy and safety of tirzepatide in Korean patients with type 2 diabetes, showing significant reductions in HbA1c and body weight.
This study evaluated the effectiveness of WeChat-delivered medical nutrition therapy for managing gestational diabetes, finding significant improvements in glucose levels and weight gain.
This study evaluated the impact of additional toothbrushing during non-surgical periodontal treatment on oral and general health in patients with type 2 diabetes, finding significant reductions in HbA1c levels.
This study evaluated the effects of adjunctive periodontal therapy with Indocyanine Green irradiation in patients with Type II diabetes and periodontitis. Significant improvements were observed in clinical outcomes.
This study investigated the impact of coenzyme Q10 supplementation alongside scaling and root planing on periodontal health in controlled diabetic patients, finding significant improvements in several periodontal indices.
This study evaluated the effects of non-surgical periodontal treatment (NSPT) on periodontal health in patients with type 2 diabetes. Key findings included significant improvements in plaque index and clinical attachment levels.
This study evaluated the effects of intensive periodontal treatment on lipid profiles and endothelial function in diabetic patients, finding significant improvements in endothelial function but no changes in lipid levels.
This study investigated the impact of low-level laser therapy combined with scaling and root planing on salivary calprotectin levels in periodontitis patients with type 2 diabetes, finding significant reductions in several clinical parameters.
This study evaluated the impact of metronidazole as an adjunct to scaling and root planing on insulin resistance in type 2 diabetes patients with periodontitis, finding significant changes in HOMA-IR at 6 months.
This study investigated the impact of non-surgical periodontal treatment on clinical indices and salivary adipokines in diabetic patients with periodontitis, finding significant improvements in several clinical measures.
This study evaluated the impact of nonsurgical periodontal treatment combined with a community health worker strategy on oral self-care behaviors in patients with Type 2 Diabetes Mellitus.
This study investigated the impact of non-surgical periodontal treatment on glycemic control and systemic inflammation in patients with Type 2 Diabetes, finding significant improvements in HbA1c and CRP levels at 6 months.
This study evaluated the effectiveness of probiotics and tetracycline fibers as adjuncts to scaling and root planing in type 2 diabetic patients with periodontitis, finding significant reductions in inflammatory markers and periodontal indices.
This study evaluated the impact of scaling and root planing on glycemic control in type 2 diabetes patients, finding significant improvements in various health markers.
This study evaluated the impact of Scaling and Root Planing with and without Low Level Laser Therapy on salivary TNF-α levels in patients with periodontitis and type 2 diabetes, finding significant reductions in several clinical parameters.
This study evaluated the effects of ertugliflozin on liver function in patients with nonalcoholic fatty liver disease and type 2 diabetes, finding significant improvements in liver-related biomarkers.
This study investigated the effects of ginger supplementation on inflammatory and periodontal parameters in type 2 diabetes patients with chronic periodontitis, finding significant reductions in several inflammatory markers.
This study evaluated the antimicrobial efficacy of three intracanal medicaments in Type II diabetes patients with chronic apical periodontitis, finding significant reductions in microbial counts.
This study investigated the impact of non-surgical periodontal therapy on plasma IL-17 levels in chronic periodontitis patients with well-controlled type II diabetes. It found significant improvements in gingival and plaque indices.
This study evaluated the effects of non-surgical periodontal therapy on plaque index and glycemic control in type 2 diabetes patients, finding significant improvements in both areas.
This study investigated the impact of ozone therapy on glycated hemoglobin levels in type 2 diabetes patients, finding no significant reduction in HbA1c levels.
This study evaluated the effects of pemvidutide on liver fat content in individuals with metabolic dysfunction-associated steatotic liver disease over 24 weeks.
Non-surgical periodontal treatment with topical antibiotics showed improvements in glycemic control among type 2 diabetes patients.
This study evaluated the impact of improved periodontal health on glycemic control in type 2 diabetes patients with generalized periodontitis, revealing significant changes in several periodontal measures.
This study compared the effects of Saroglitazar and Pioglitazone on liver health and blood sugar control in patients with Type 2 Diabetes and liver disease, finding significant improvements in certain measures.
This study investigated the effects of a multispecies probiotic supplement combined with non-surgical periodontal therapy in patients with type 2 diabetes, finding significant improvements in inflammatory and periodontal markers.
The study evaluated the effects of Tirzepatide combined with either Low-Energy Ketogenic Therapy or Low-Calorie Diet on hepatic steatosis in patients with MASLD, finding significant improvements in liver parameters.
This study examined the effects of vitamin C supplementation on periodontal health in type 2 diabetes patients and found no significant improvement in periodontal status.
This study evaluated the efficacy and safety of dapagliflozin in participants with metabolic dysfunction-associated steatohepatitis (MASH), finding significant improvements in liver health outcomes.
This study analyzed health-related quality of life (HRQoL) in dietary interventions for type 2 diabetes, finding improvements in both low-carbohydrate high-fat (LCHF) and high-carbohydrate low-fat (HCLF) diets.
This study examined the effects of Empagliflozin on liver health in patients with Type 2 Diabetes Mellitus, finding significant improvements in liver fat and liver enzyme levels.
The study investigated the effects of adding Empagliflozin to standard treatment in patients with Type 2 Diabetes, finding significant reductions in hepatic fat mass and BMI.
This study evaluated the effects of combined high-intensity interval training and progressive resistance training on overweight/obese adults, finding significant improvements in hepatic steatosis and fitness metrics.
This study investigated the impact of various interventions on metabolic health in individuals with type 2 diabetes, finding significant improvements in body weight, insulin sensitivity, triglycerides, and HbA1c levels.
The Phase 2b trial evaluated the safety and efficacy of MK-3655 in patients with pre-cirrhotic MASH. Results showed varying rates of MASH resolution and liver fat content reduction across different doses.
The study investigated the effects of combined treatment with pioglitazone and metformin on liver fat in type 2 diabetes patients, finding a significant reduction in liver fat content.
This study evaluated the effects of semaglutide on lipid profiles and liver parameters in patients with type 2 diabetes and obesity, showing significant improvements.
This study evaluated the effectiveness of tirzepatide in resolving metabolic dysfunction-associated steatohepatitis (MASH) without worsening fibrosis.
This study investigated the effects of Vildagliptin and Metformin on hepatic steatosis in newly diagnosed Type 2 diabetes patients, showing significant improvements in various metabolic parameters.
This study compared the effects of liraglutide and lifestyle counseling on metabolic outcomes in obese individuals with prediabetes or early type 2 diabetes, finding comparable improvements in key metrics.
The IDEATE study examined the effects of a 5:2 diet and exercise on glycemic control in newly diagnosed type 2 diabetes patients, finding significant improvements in HbA1c levels with the diet.
This study evaluated the combination therapy of Tofogliflozin and Pioglitazone for treating hepatic steatosis in patients with NAFLD and T2DM, showing significant improvements in various metabolic parameters.
This study evaluated the effects of dietary fiber supplementation on liver fibrosis and glycemic control in patients with Type 2 diabetes and MASLD, finding significant improvements in HbA1c and FIB-4 levels.
This study explored the impact of a low-carbohydrate, energy-restricted diet on beta-cell function and liver fat in adults with Type 2 diabetes, finding significant reductions in liver fat and insulin resistance.
This study evaluated the safety and potential therapeutic effects of orally delivered insulin in patients with metabolic dysfunction-associated steatohepatitis and type 2 diabetes mellitus, finding significant reductions in liver fat and fibrosis levels.
This study investigated the efficacy of pioglitazone in treating NAFLD patients with abnormal glucose metabolism, revealing significant liver fat content reduction in women compared to men.
This study investigated the effects of semaglutide on vascular and liver function in patients with type 2 diabetes and nonalcoholic fatty liver disease, finding significant improvements in various health markers.
This study investigated the effects of testosterone therapy on liver fat in men with type 2 diabetes and low testosterone levels, finding a significant reduction in liver fat compared to placebo.
Entities
New intervention and outcome entities created during this weekly snapshot.
EvidenceScore™
Evidence Updates
Build your workspace and revisit the evidence that matters most to you.